Autopsy report · NCT02243696
Protego DF4 Post Approval Registry
Cause of deathRegulatory or ethics
“On April 15, 2019, BIOTRONIK received FDA approval to transition the ongoing Protego DF4 Post Approval Registry to a new EP PASSION real-world data methodology.”
Life of this trial
- Ran for about 4 years 7 months before it stopped.
- 1,694 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Sponsor
- Biotronik, Inc.
- Sponsor type
- Industry
- Conditions
- Implantable Defibrillator User
- Participants
- 1,694
- Sites
- 68
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.